MktsMarkets

AbCellera Biologics Inc.
NASDAQ: ABCLKey statistics
ABCL News
Stories mentioning ABCL from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 8,315 | 44,854 | 8,955 | 17,084 | 4,235 | 5,049 | 6,507 | 7,323 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 46,662 | 50,092 | 55,028 | 39,213 | 42,496 | 46,076 | 40,969 | 40,927 |
| Sales General & Admin | 12,334 | 19,068 | ||||||
| Total Operating Expenses | 65,834 | 73,434 | 85,233 | 66,669 | 66,895 | 77,804 | 100,170 | 100,777 |
| Operating Income (Loss) | (57,519) | (28,580) | (76,278) | (49,585) | (62,660) | (72,755) | (93,663) | (93,454) |
| Interest Income | 3,643 | 8,449 | 6,765 | 7,592 | 5,523 | 8,668 | 9,603 | 9,801 |
| Interest Expense | ||||||||
| Other Expense | (156.00) | (1,984) | 1,957 | (2,528) | 13,714 | 17,937 | 32,156 | |
| Pretax Income | (49,537) | (19,499) | (68,768) | (36,344) | (52,984) | (46,829) | (62,632) | (48,187) |
| Tax Provision | (6,372) | (10,554) | (11,649) | (1,617) | (7,363) | (12,619) | (11,525) | (11,257) |
| Net Income (Loss) | (43,165) | (8,945) | (57,119) | (34,727) | (45,621) | (34,210) | (51,107) | (36,930) |
| Earnings Per Share (Basic) | (0.14) | (0.03) | (0.19) | (0.12) | (0.15) | (0.12) | (0.17) | (0.13) |
| Earnings Per Share (Diluted) | (0.14) | (0.03) | (0.19) | (0.12) | (0.15) | (0.12) | (0.17) | (0.13) |
| Weighted Average Shares Outstanding (Basic) | 303,075 | 298,707 | 298,875 | 298,509 | 297,693 | 294,328 | 294,852 | 294,217 |
| Weighted Average Shares Outstanding (Diluted) | 303,075 | 298,707 | 298,875 | 298,509 | 297,693 | 294,328 | 294,852 | 294,217 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ABCL
AbCellera Biologics Inc. (NASDAQ: ABCL) is a stock listed on the Nasdaq Stock Market under the ticker symbol ABCL. It last traded at $12.28 (Nov 4, 2026, 4:00 PM ET), up 0.8% on the day. That gives AbCellera Biologics a market capitalisation of $4.0B.
Over the past 52 weeks ABCL has traded between $2.75 and $15.02.
Revenue for the quarter ended Mar 31, 2026 was $8.3M; a net loss of $43.2M. Revenue was up 96.3% from $4.2M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $8.3M | -$43.2M | -519.1% |
| Dec 31, 2025 | $44.9M | -$8.9M | -19.9% |
| Sep 30, 2025 | $9.0M | -$57.1M | -637.8% |
| Jun 30, 2025 | $17.1M | -$34.7M | -203.3% |
From AbCellera Biologics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…